Multivalent Nanoparticle Networks Enable Point-of-Care Detection of Human Phospholipase-A2 in Serum
Source abstract
Abstract
A rapid and highly sensitive point-of-care (PoC) lateral flow assay for phospholipase A2 (PLA2) is demonstrated in serum through the enzyme-triggered release of a new class of biotinylated multiarmed polymers from a liposome substrate. Signal from the enzyme activity is generated by the adhesion of polystreptavidin-coated gold nanoparticle networks to the lateral flow device, which leads to the appearance of a red test line due to the localized surface plasmon resonance effect of the gold. The use of a liposome as the enzyme substrate and multivalent linkers to link the nanoparticles leads to amplification of the signal, as the cleavage of a small amount of lipids is able to release a large amount of polymer linker and adhesion of an even larger amount of gold nanoparticles. By optimizing the molecular weight and multivalency of these biotinylated polymer linkers, the sensitivity of the device can be tuned to enable naked-eye detection of 1 nM human PLA2 in serum within 10 min. This high sensitivity enabled the correct diagnosis of pancreatitis in diseased clinical samples against a set of healthy controls using PLA2 activity in a point-of-care device for the first time.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Biosensors and Analytical Detection · Advanced biosensing and bioanalysis techniques · SARS-CoV-2 detection and testing
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials, Department of Bioengineering and Institute for Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.
Mologic Ltd., Bedford Technology Park, Thurleigh, Bedfordshire MK44 2YP, U.K.
Hepatology and Gastroenterology Section, Faculty of Medicine, St Mary’s Hospital Campus, Imperial College London, London W2 1NY, U.K.
Funding
Technology Strategy Board · European Research Council · Engineering and Physical Sciences Research Council
References (44)
Show source-provided references
1. Cirino G. · Biochem. Pharmacol. · 1998 · 55 · 10510.1016/S0006-2952(97)00215-3 ↗
2. Dennis E. A. · J. Biol. Chem. · 1994 · 269 · 1305710.1016/S0021-9258(17)36794-7 ↗
3. Kugiyama K. · Circulation · 1999 · 100 · 128010.1161/01.CIR.100.12.1280 ↗
4. Eskola J. U. · Clin. Chem. · 1988 · 34 · 105210.1093/clinchem/34.6.1052 ↗
5. Schrama A. J. J. · J. Perinatol. · 2008 · 28 · 29110.1038/sj.jp.7211929 ↗
6. Menschikowski M. · Inflammation · 2012 · 35 · 111310.1007/s10753-011-9418-1 ↗
7. Dong Z. · Carcinogenesis · 2010 · 31 · 194810.1093/carcin/bgq188 ↗
8. Kupert E. · BMC Cancer · 2011 · 11 · 51310.1186/1471-2407-11-513 ↗
9. Chemburu S. · J. Phys. Chem. B · 2008 · 112 · 1449210.1021/jp803358j ↗
10. Feng L. · Chem. Biol. · 2002 · 9 · 79510.1016/S1074-5521(02)00168-0 ↗
11. Okada S. Y. · Angew. Chem., Int. Ed. · 1999 · 38 · 65510.1002/(SICI)1521-3773(19990301)38:5<655::AID-ANIE655>3.0.CO;2-4 ↗
12. Dennis E. A. · Chem. Rev. · 2011 · 111 · 613010.1021/cr200085w ↗
13. Lee D.-S. · Lab Chip · 2011 · 11 · 12010.1039/C0LC00209G ↗
14. Martinez A. W. · Anal. Chem. · 2008 · 80 · 369910.1021/ac800112r ↗
15. Xiao Z. · Chem. Commun. · 2012 · 48 · 854710.1039/c2cc33931e ↗
16. Rohrman B. A. · PLoS One · 2012 · 7 · e4561110.1371/journal.pone.0045611 ↗
17. Xu H. · Anal. Chem. · 2009 · 81 · 66910.1021/ac8020592 ↗
18. Liu G. · Anal. Chem. · 2009 · 81 · 1001310.1021/ac901889s ↗
19. Mazumdar D. · Chem. Commun. · 2010 · 46 · 141610.1039/b917772h ↗
20. Liu J. · Angew. Chem., Int. Ed. · 2006 · 45 · 795510.1002/anie.200603106 ↗
21. Saha K. · Chem. Rev. · 2012 · 112 · 273910.1021/cr2001178 ↗
22. Howes P. D. · Chem. Soc. Rev. · 2014 · 43 · 383510.1039/C3CS60346F ↗
23. Jans H. · Chem. Soc. Rev. · 2012 · 41 · 284910.1039/C1CS15280G ↗
24. Jain P. K. · J. Phys. Chem. B · 2006 · 110 · 723810.1021/jp057170o ↗
25. Laromaine A. · J. Am. Chem. Soc. · 2007 · 129 · 415610.1021/ja0706504 ↗
26. Elghanian R. · Science · 1997 · 277 · 107810.1126/science.277.5329.1078 ↗
27. Du J. · Small · 2013 · 9 · 146710.1002/smll.201200811 ↗
28. Aili D. · Nano Lett. · 2011 · 11 · 556410.1021/nl203559s ↗
29. Aili D. · Nano Lett. · 2011 · 11 · 140110.1021/nl1024062 ↗
30. Mammen M. · Angew. Chem., Int. Ed. · 1998 · 37 · 275510.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 ↗
31. Lim Y.-b. · Org. Biomol. Chem. · 2007 · 5 · 40110.1039/B615744K ↗
32. Huskens J. · Curr. Opin. Chem. Biol. · 2006 · 10 · 53710.1016/j.cbpa.2006.09.007 ↗
33. Fasting C. · Angew. Chem., Int. Ed. · 2012 · 51 · 1047210.1002/anie.201201114 ↗
34. de la Rica R. · Angew. Chem., Int. Ed. · 2011 · 50 · 5703
35. Marsh D. · Biochim. Biophys. Acta, Biomembr. · 2003 · 1615 · 3310.1016/S0005-2736(03)00197-4 ↗
36. Li H. Y. · J. Am. Chem. Soc. · 2004 · 126 · 41810.1021/ja0383367 ↗
37. Chen C. · J. Controlled Release · 2010 · 142 · 29910.1016/j.jconrel.2009.10.024 ↗
38. Xu W. · J. Biol. Chem. · 2009 · 284 · 1665910.1074/jbc.M808029200 ↗
39. Nevalainen T. J. · Gut · 1993 · 34 · 113310.1136/gut.34.8.1133 ↗
40. Green J. A. · Inflammation · 1991 · 15 · 35510.1007/BF00917352 ↗
41. Pruzanski W. · J. Rheumatol. · 1985 · 12 · 211
42. Koenig W. · Eur. Heart. J. · 2009 · 30 · 274210.1093/eurheartj/ehp302 ↗
43. Dutour A. · J. Clin. Endocrinol. Metab. · 2010 · 95 · 96310.1210/jc.2009-1222 ↗
44. Schevitz R. W. · Nat. Struct. Biol. · 1995 · 2 · 45810.1038/nsb0695-458 ↗